Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PHST001 |
| Trade Name | |
| Synonyms | PHST 001|PHST-001 |
| Drug Descriptions |
PHST001 is a monoclonal antibody targeting CD24, which potentially induces macrophage-dependent tumor cell phagocytosis and inhibits tumor growth (Journal for ImmunoTherapy of Cancer 2024;12). |
| DrugClasses | CD24 Antibody 3 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Doxorubicin + PHST001 | Doxorubicin PHST001 | 0 | 1 |
| Fluorouracil + Irinotecan + Leucovorin + PHST001 | Fluorouracil Irinotecan Leucovorin PHST001 | 0 | 1 |
| Fluorouracil + Leucovorin + Oxaliplatin + PHST001 | Fluorouracil Leucovorin Oxaliplatin PHST001 | 0 | 1 |
| Gemcitabine + PHST001 | Gemcitabine PHST001 | 0 | 1 |
| Paclitaxel + PHST001 | PHST001 Paclitaxel | 0 | 1 |
| PHST001 | PHST001 | 0 | 1 |
| PHST001 + Topotecan | PHST001 Topotecan | 0 | 1 |